Agency pledges focus on post-market safety info
James G. Dickinson
January 01 2007
The FDA says drug safety improvements at the agency will focus on the quality of post-market safety information received, new ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.